At a glance
ClinicalIndex Comparison RecordPhase 1Completed· 12 enrolled
Drug / intervention
PF-04958242 +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Phase 1, Randomized, Subject- And Investigator-blind, Sponsor Open, Placebo Controlled, Single Ascending Dose Escalation Study To Evaluate The Safety, Tolerability And Pharmacokinetics Of Pf-04958242 Following Oral Dose Capsules in Healthy Subjects
In Brief
A Phase 1 clinical trial evaluating PF-04958242 and Placebo for Healthy. Completed, enrolled 12 participants across 1 site.
Detailed Summary
This study aims to assess the safety, tolerability, and pharmacokinetics of PF-04958242 at a number of single ascending doses in healthy volunteers
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy
CountriesUnited States
Collaborators--
Timeline
Phase 1CompletedFinished
201520162017201820192020202120222023202420252026
First PostedAug 2014
Enrollment StartSep 2014
Primary CompletionNov 2014
TodayJul 2026
First PostedAug 29, 2014
Enrollment StartSep 22, 2014
Primary CompletionNov 13, 2014
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 11.8 years ago
Interventions
PF-04958242drug
Administered as specified in treatment arm
Placebodrug
Administered as specified in treatment arm